These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8700802

  • 1. Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases.
    Zhang H, Hoang T, Saeed B, Ng SC.
    Prostate; 1996 Aug; 29(2):69-76. PubMed ID: 8700802
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.
    Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M.
    Cancer Res; 2001 Feb 15; 61(4):1699-706. PubMed ID: 11245486
    [Abstract] [Full Text] [Related]

  • 3. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec 15; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 4. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG, Li L, Chopra DP, Porter AT.
    Cancer Res; 1998 Aug 01; 58(15):3466-79. PubMed ID: 9699682
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 6. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M, Raffo AJ, Benimetskaya L, Shames D, Stein CA.
    Cancer Res; 2002 Apr 01; 62(7):2175-83. PubMed ID: 11929841
    [Abstract] [Full Text] [Related]

  • 7. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS, Cho-Chung YS.
    Clin Cancer Res; 2003 Mar 01; 9(3):1171-8. PubMed ID: 12631623
    [Abstract] [Full Text] [Related]

  • 8. Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL.
    Giuliano M, Bellavia G, Lauricella M, D'Anneo A, Vassallo B, Vento R, Tesoriere G.
    Int J Mol Med; 2004 Apr 01; 13(4):565-71. PubMed ID: 15010857
    [Abstract] [Full Text] [Related]

  • 9. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC.
    Oncogene; 2003 Jul 17; 22(29):4498-508. PubMed ID: 12881706
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 17; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 11. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH.
    Int J Oncol; 2003 Apr 17; 22(4):787-94. PubMed ID: 12632069
    [Abstract] [Full Text] [Related]

  • 12. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
    Zangemeister-Wittke U, Leech SH, Olie RA, Simões-Wüst AP, Gautschi O, Luedke GH, Natt F, Häner R, Martin P, Hall J, Nalin CM, Stahel RA.
    Clin Cancer Res; 2000 Jun 17; 6(6):2547-55. PubMed ID: 10873111
    [Abstract] [Full Text] [Related]

  • 13. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
    Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB.
    Oncogene; 2001 Nov 15; 20(52):7597-609. PubMed ID: 11753638
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J, Petak I, Szucs KS, Nagy K, Tillman DM, Houghton JA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6504-15. PubMed ID: 14695155
    [Abstract] [Full Text] [Related]

  • 18. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells.
    Day ML, Zhao X, Wu S, Swanson PE, Humphrey PA.
    Cell Growth Differ; 1994 Jul 15; 5(7):735-41. PubMed ID: 7947388
    [Abstract] [Full Text] [Related]

  • 19. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
    Kikugawa T, Kinugasa Y, Shiraishi K, Nanba D, Nakashiro K, Tanji N, Yokoyama M, Higashiyama S.
    Prostate; 2006 Jul 01; 66(10):1092-9. PubMed ID: 16637071
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B.
    Oncogene; 2004 Jun 24; 23(29):4993-5003. PubMed ID: 15048072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.